The cost-effectiveness of aspirin for chemoprevention of colorectal cancer

被引：1

作者：

Provenzale, D ^{[1
]}

机构：

[1] Duke Univ, Sch Med, Durham, NC USA

来源：

GASTROENTEROLOGY | 2002年 / 122卷 / 01期

关键词：

D O I：

10.1053/gast.2002.30618

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：230 / 233

页数：4

共 10 条

[1]

Bloom B S, 1988, Am J Med, V84, P20, DOI 10.1016/0002-9343(88)90250-1

[2]

Gold MR, 1996, COST EFFECTIVENESS H

[3] An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease [J].

Hebert, PR ;

Hennekens, CH .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (20) :3123-3127

[4]

Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043

[5]

Rahme E, 2000, ARTHRITIS RHEUM-US, V43, P917, DOI 10.1002/1529-0131(200004)43:4<917::AID-ANR25>3.0.CO

[6]

2-F

[7] Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs [J].

Smalley, WE ;

Griffin, MR ;

Fought, RL ;

Ray, WA .

JOURNAL OF GENERAL INTERNAL MEDICINE, 1996, 11 (08) :461-469

[8] Cost-effectiveness of colonoscopy in screening for colorectal cancer [J].

Sonnenberg, A ;

Delcò, F ;

Inadomi, JM .

ANNALS OF INTERNAL MEDICINE, 2000, 133 (08) :573-584

[9] Chemoprevention of colorectal cancer by aspirin: A cost-effectiveness analysis [J].

Suleiman, S ;

Rex, DK ;

Sonnenberg, A .

GASTROENTEROLOGY, 2002, 122 (01) :78-84

[10]

Wagner JL., 1996, Prevention and early detection of colorectal cancer, P321

← 1 →